Trial intelligence / Profile preview

Topical vs Systemic Antibiotics for Burn Wound Infection in Pediatric Patients

NCT07870239Not yet recruiting

Start
Nov 2026
Primary completion
May 2027
Countries
1
01

Overview

Randomised trial of amoxicillin + clavulanate in burn wound infection (2 arms). Primary endpoint: Incidence of burn wound infection at 14 days. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

amoxicillin + clavulanate
03

Conditions

burn wound infection

Beyond the preview

Go deeper on NCT07870239.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07870239.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call